Actinobacillus pleuropneumoniae
Association between transmission rate and disease severity for Actinobacillus pleuropneumoniae infection in pigs
10
Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae
13
Adhesion Protein ApfA of Actinobacillus pleuropneumoniae Is Required for Pathogenesis and Is a Potential Target for Vaccine Development
8
Improved Diagnostic PCR Assay for Actinobacillus pleuropneumoniae Based on the Nucleotide Sequence of an Outer Membrane Lipoprotein
6
Molecular characterisation of the early response in pigs to experimental infection with Actinobacillus pleuropneumoniae using cDNA microarrays
11
Detection and Identification of Actinobacillus pleuropneumoniae Serotypes 1, 2, and 8 by Multiplex PCR
5
Frequency of Th17 cells correlates with the presence of lung lesions in pigs chronically infected with Actinobacillus pleuropneumoniae
16
What is the true in vitro potency of oxytetracycline for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida?
13
Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media
28
In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae
11
ICEApl1, an integrative conjugative element related to ICEHin1056, identified in the pig pathogen Actinobacillus pleuropneumoniae
8
Genetic Diversity of Actinobacillus pleuropneumoniae Assessed by Amplified Fragment Length Polymorphism Analysis
9
PR 39, a porcine host defence peptide, is prominent in mucosa and lymphatic tissue of the respiratory tract in healthy pigs and pigs infected with actinobacillus pleuropneumoniae
7
Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
28
Actinobacillus pleuropneumoniae induces SJPL cell cycle arrest in G2/M phase and inhibits porcine reproductive and respiratory syndrome virus replication
15
Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae
12
Pharmacokinetic/pharmacodynamic integration and modelling of oxytetracycline for the porcine pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida
12
Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis
24
Construction of a DNA probe and detection of Actinobacillus pleuropneumoniae by using polymerase chain reaction
5
Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis
6